Key result
Croatian patients undergoing cardiac resynchronization therapy received a CRT-pacemaker significantly more often than the broader European cohort (58.3% vs. 29.9%; OR 3.27, 95% CI 2.25-4.74, p<0.001).
Why the study?
How does Croatian national CRT practice compare with European data regarding patient selection and device types?
Observational (n=115)
Yes
How does Croatian national CRT practice compare with European data regarding patient selection and device types?
Croatian CRT practice demonstrates strict patient selection and a significantly higher use of CRT-P compared to the rest of Europe, likely driven by local healthcare organization and reimbursement policies.
Aims . The Cardiac Resynchronization Therapy (CRT) Survey II was conducted between October 2015 and December 2016 and included data from 11088 CRT implantations from 42 countries. The survey’s aim was to report on current European CRT practice. The aim of this study was to compare the Croatian national CRT practice with the European data. Methods . Five centres from Croatia recruited consecutive patients, in a 15-month period, who underwent CRT implantation, primary or an upgrade. Data were collected prospectively by using online database. Results . A total of 115 patients were included in Croatia, which is 33.2% of all CRT implants in Croatia during the study period (total n=346). Median age of the study population was 67 (61–73) years, and 21.2% were women. Primary heart failure (HF) aetiology was nonischemic in 61.1% of patients, and HF with wide QRS was the most common indication for the implantation (73.5%). 80% of patients had complete left bundle branch block, and over two-third had QRS ≥150 ms. Device-related adverse events were recorded in 4.3% of patients. When compared with European countries, Croatian patients were significantly younger (67 vs. 70 years, p=0.012), had similar rate of comorbidities with the exception of higher prevalence of hypertension. Croatian patients significantly more often received CRT-pacemaker when compared with European population (58.3 vs. 29.9%, OR 3.27, 95%CI 2.25–4.74, p<0.001). Conclusion . Our data indicate strict selection of patients among HF population and adherence to guidelines with exception of higher proportion of CRT-pacemaker implantation. This is likely to be influenced by healthcare organization and reimbursement issues in Croatia.
No takes yet. Share an insight, caveat, or question.
Brusich et al. (2018) conducted an observational in Heart failure requiring cardiac resynchronization therapy (CRT) (n=115). Croatian healthcare setting vs. European healthcare setting was evaluated on Receipt of CRT-pacemaker (OR 3.27, 95% CI 2.25-4.74, p=<0.001). Croatian patients undergoing cardiac resynchronization therapy received a CRT-pacemaker significantly more often than the broader European cohort (58.3% vs. 29.9%; OR 3.27, 95% CI 2.25-4.74, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: